文献速递乳房整形与再造显微修复重建

医生报酬对显微血管乳房重建的影响:全支付方理赔数据库分析

Impact of Physician Payments on Microvascular Breast Reconstruction: An All-Payer Claim Database Analysis.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

基于马萨诸塞州全支付方理赔数据库2010至2014年立即自体或假体乳房重建女性的数据,比较不同保险类型下显微血管自体乳房重建与假体的医生报酬差异及其对重建方式选择的影响。结果显示政府保险者接受显微重建比例低于商业保险,且医生报酬越高显微重建可能性越大,提示当前显微重建报酬可能未充分体现医生工作量。

要点

  • 政府保险者显微血管自体乳房重建比例低于商业保险者(16.4% vs 20.3%,p=0.063)。
  • 显微重建医生报酬中位数政府保险较商业保险低78%($1831 vs $8435)。
  • 医生报酬增加与显微重建可能性增加独立相关(p<0.001)。

核心结论

  • 政府保险女性接受显微血管自体乳房重建的几率低于商业保险者。
  • 无论支付方类型,显微重建报酬越高,接受显微重建的可能性越大。
  • 当前显微自体乳房重建报酬与假体技术相比可能未充分体现医生工作量。

研究设计与样本

  • 基于马萨诸塞州全支付方理赔数据库的回顾性分析,纳入2010至2014年接受立即自体或假体乳房重建的女性。
  • 采用单因素分析比较不同重建方式的人口学与临床特征,并用逻辑回归探索保险类型与医生报酬对重建方式的相对影响。
  • 证据等级为风险类II级。

主要发现

  • 研究中82.7%女性为商业保险,17.3%为政府保险。
  • 80%女性接受假体重建,20%接受显微血管自体重建。
  • 政府保险者接受显微重建比例为16.4%,商业保险者为20.3%(p=0.063)。
  • 商业保险、年龄较大和肥胖独立增加显微重建的几率(p<0.01)。
  • 显微重建医生报酬中位数政府保险为$1831,商业保险为$8435,政府保险低78%。

临床怎么用

  • 在讨论显微血管自体乳房重建与假体重建时,可考虑保险类型和医生报酬对术式选择的潜在影响。
  • 关注政府保险与商业保险间显微重建报酬差异对患者获得显微重建机会的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rates of autologous breast reconstruction are stagnant compared with prosthetic techniques. Insufficient physician payment for microsurgical autologous breast reconstruction is one possible explanation. The payment difference between governmental and commercial payers creates a natural experiment to evaluate its impact on method of reconstruction. This study assessed the influence of physician payment differences for microsurgical autologous breast reconstruction and implants by insurance type on the likelihood of undergoing microsurgical reconstruction. METHODS: The Massachusetts All-Payer Claims Database was queried for women undergoing immediate autologous or implant breast reconstruction from 2010 to 2014. Univariate analyses compared demographic and clinical characteristics between different reconstructive approaches. Logistic regression explored the relative impact of insurance type and physician payments on breast reconstruction modality. RESULTS: Of the women in this study, 82.7 percent had commercial and 17.3 percent had governmental insurance. Implants were performed in 80 percent of women, whereas 20 percent underwent microsurgical autologous reconstruction. Women with Medicaid versus commercial insurance were less likely to undergo microsurgical reconstruction (16.4 percent versus 20.3 percent; p = 0.063). Commercial insurance, older age, and obesity independently increased the odds of microsurgical reconstruction (p < 0.01). When comparing median physician payments, governmental payers reimbursed 78 percent and 63 percent less than commercial payers for microsurgical reconstruction ($1831 versus $8435) and implants ($1249 versus $3359, respectively). Stratified analysis demonstrated that as physician payment increased, the likelihood of undergoing microsurgical reconstruction increased, independent of insurance type (p < 0.001). CONCLUSIONS: Women with governmental insurance had lower odds of undergoing microsurgical autologous breast reconstruction compared with commercial payers. Regardless of payer, greater reimbursement for microsurgical reconstruction increased the likelihood of microsurgical reconstruction. Current microsurgical autologous breast reconstruction reimbursements may not be commensurate with physician effort when compared to prosthetic techniques. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Panchal H, Shamsunder MG, Sheinin A, et al. Impact of Physician Payments on Microvascular Breast Reconstruction: An All-Payer Claim Database Analysis. Plast Reconstr Surg. 2020. PMID: 31985616. doi:10.1097/PRS.0000000000006453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。